Publications by authors named "Roberta Volpi"

Claim this Profile
I
INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia.
Cristina Papayannidis, Elisabetta Petracci, Patrizia Zappasodi, Nicola Fracchiolla, Fabio Ciceri, Roberta Volpi

Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront intensive treatment analysis of the Italian Cohort Study on FLT3-mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real-life setting.
Jacopo Nanni, Irene Azzali, Cristina Papayannidis, Antonino Mulè, Ernesta Audisio, Roberta Volpi

Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Bicocca sampling days model: a participatory citizen science approach to environmental microbiome research and education.
Giulia Ghisleni, Alice Armanni, Sara Fumagalli, Asia Rosatelli, Yodit M Bacchi, Roberta Volpi

ISME Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can natural immunity partially replace vaccine against SARS-COV2 infection? A small single center study.
Graziella Bonetti, Gianpaolo Chitoni, Alessandra Bettinardi, Gianluca Borrelli, Gianfranco Fiordalisi, Roberta Volpi

Minerva Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Elisabetta Todisco, Cristina Papayannidis, Nicola Fracchiolla, Elisabetta Petracci, Chiara Zingaretti, Roberta Volpi

Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical research activities during COVID-19: the point of view of a promoter of academic clinical trials.
Linda Valmorri, Bernadette Vertogen, Chiara Zingaretti, Anna Miserocchi, Roberta Volpi

BMC Med Res Methodol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer.
Andrea Rocca, Pietro Cortesi, Laura Cortesi, Lorenzo Gianni, Federica Matteucci, Roberta Volpi

Ther Adv Med Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinalysis parameters for predicting severity in coronavirus disease 2019 (COVID-19).
Graziella Bonetti, Filippo Manelli, Alessandra Bettinardi, Gianluca Borrelli, Gianfranco Fiordalisi, Roberta Volpi

Clin Chem Lab Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
Graziella Bonetti, Filippo Manelli, Andrea Patroni, Alessandra Bettinardi, Gianluca Borrelli, Roberta Volpi

Clin Chem Lab Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System of Natural Health Products.
Angelica Paoletti, Eugenia Gallo, Silvia Benemei, Michele Vietri, Francesco Lapi, Roberta Volpi

Evid Based Complement Alternat Med· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholinesterase inhibitors exert a protective effect on endothelial damage in Alzheimer disease patients.
Barbara Borroni, Chiara Agosti, Giuliana Martini, Roberta Volpi, Cristina Brambilla

J Neurol Sci· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis